spring forecast call winter
push loss
issu preliminari guidanc call light
prevail street expect lower full-year guid midpoint
account relat impact importantli figur reflect delay
instal across apac lesser extend eu stem take
accordingli recogn downsid could materi across
geographi run cours
top-lin hit midpoint mostli apac eu relat
guidanc translat report equat roughli
guidanc lower report prior report result
shortfal versu prior rang outlook predominantli reflect
relat headwind across apac lesser extent eu region itali call
call specif hit predominantli associ delay instal
china hospit lesser extent japan due quarantin bottleneck procedur
delay resourc alloc toward outbreak order side
co reiter demand rt solut among china hospit appear unchang
given chang least date momentum mid-teen last
translat ep roughli w/no chang co
indic would provid updat call top-lin
impact flow full-year ep current rang sit face
valu top-lin reduct translat bottom line impact
assum assumpt unchang adj om tax rate
share though detail light co refer despit
headwind spend commit like remain unchang suggest potenti
risk adj om target revenu push-out factor
us rest eu move target junctur best guess
although itali call call revis appear bake
signific pressur across major eu territori us point
alloc guidanc revis predominantli apac math work
geograph impact appli impact america mix equat
theoret headwind scenario plausibl would
endors level impact junctur given myriad unknown associ
handicap us headwind
lower pt stori work pig get python
goe prior reflect headwind coupl
continu commit ramp invest outer-year reflect gradual
recaptur procedures/instal beyond lower pt
prior reflect valuat reset risk still see upsid
clearer sky
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
low-teen growth global oncolog order support
china demand india uptak us upgrad
rel seamless transit value-bas care
reimburs model us
rang
support halcyon convers softwar mix tariff
major chang us-china tariff polici
pt reach break-even
larg scale next
pt use blend approach consid pe
ebitda sotp dcf methodolog
mid-teen growth global oncolog order support
china demand india uptak us upgrad
major impact transit value-bas care
reimburs model us come
oncolog gm expand support halcyon
us-china tariff polici eas drive ep upsid
pt reach break-even
 next growth ep accret
pt use blend approach consid pe
ebitda sotp dcf methodolog
hsd growth global oncolog order driven
slower china demand india uptak us upgrad
transit value-bas care reimburs model
us advers affect linac demand
oncolog gm declin lower demand
pt use blend approach consid pe
ebitda sotp dcf methodolog
us-china tariff polici tighten lead
cost ep downsid
pt reach break-even
 next prove growth ep
buy thesi predic gross oncolog order
sustain teen driven china/india uptak
us upgrad maintain lead posit
healthi clip margin upsid halcyon
convers softwar mix
work differenti base sever proprietari
survey w/ us physician kol meet industry-
us-china tariff mitig effort announc
clinic updat softwar flash
pleas see import disclosur inform page report
pleas see import disclosur inform page report
eoctdecmarjunsepoctdecmarjunsepoctoctoctocttot growth y/ytot cost sale margin expensesr oper incom incom earn loss tax incom minor interest incom common item tax incom ep fulli growth outstand outstand exhibit revenu model
pleas see import disclosur inform page report
